Active	Status	Sponsor type	Region	Phase	Filter
6 Active 7 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Krishnamurthi, Smitha
AZUR-2, NCT05855200: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer	Recruiting	3	711	Europe, Canada, Japan, US, RoW	Dostarlimab, CAPEOX, FOLFOX	GlaxoSmithKline	Colonic Neoplasms, Neoplasms, Colon	12/28	12/30
C-800-25, NCT05608044: A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer	Active, not recruiting	2	234	Europe, US, RoW	Botensilimab, AGEN1181, Balstilimab, AGEN2034, Standard of Care	Agenus Inc.	Metastatic Colorectal Cancer	02/25	07/25
NCT05221320: Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies	Terminated	2	47	US	Ulixertinib, BVD-523, BVD523, Hydroxychloroquine	BioMed Valley Discoveries, Inc	Tumor, Solid, Gastrointestinal Cancer	05/24	07/24